Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.87 USD | -0.84% | +5.32% | -21.65% |
May. 29 | Zentalis Pharmaceuticals Announces Appointment of Luke Walker, M.D., to Board of Directors | CI |
May. 24 | Zentalis Says Azenosertib Combo Shows 'Promise' in Relapsed Osteosarcoma Trial | MT |
Evolution of the average Target Price on Zentalis Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Zentalis Pharmaceuticals, Inc.
Stifel Nicolaus | |
Wedbush | |
UBS | |
Morgan Stanley | |
HC Wainwright | |
Wells Fargo Securities | |
Jefferies & Co. | |
Guggenheim | |
SVB Securities LLC | |
Oppenheimer | |
Cowen | |
SVB Leerink |
EPS Revisions
- Stock Market
- Equities
- ZNTL Stock
- Consensus Zentalis Pharmaceuticals, Inc.